𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term treatment with low doses of interleukin-2 and interferon-α: immunological effects in advanced renal cell cancer

✍ Scribed by Laura Pavone; Simeone Andrulli; Rosaria Santi; Maria Majori; Carlo Buzio

Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
184 KB
Volume
50
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thirteen-year, long-term efficacy of int
Thirteen-year, long-term efficacy of interferon 2α and interleukin 2-based home therapy in patients with advanced renal cell carcinoma
✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t

Sequential treatment of patients with ad
Sequential treatment of patients with advanced renal cell carcinoma with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon α2b
✍ S. Pomer; R. Thiele; V. Daniel; R. Weimer; H. Löhrke; V. Schirrmacher; G. Staehl 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 820 KB

Thirty patients with advanced renal cell carcinoma (RCC), 23 of whom had distant metastases in at least one organ, were entered after nephrectomy into a protocol involving vaccination with Newcastle disease virus (NDV)-modified autologous tumour material, with a subsequent induction week and repetit